Talk about 50 new violations
Release time:
2023-03-04
2022 11 1 , the leader sent 50 new violation links in our quality management department group. The new 50 violations are combined with the 50 violations of the 2021 edition. In view of the frequent accident cases in enterprises, the violation regulations are tailored for peak employees.
The 50 new violations are equivalent to students' wrong problem books, pointing out the frequent violation habits of employees, correcting them and cultivating good habits. It is a very useful chicken soup for employees to arm the brain; it is an effective booster for enterprise safety management; it is an effective guarantee for safe production. In a word, it is a treasure. We should not only be able to recite it, but also understand it thoroughly and be good at applying it to practice.
Everyone is not in the era of Xiao Erlang. As we enter middle age, our bodies begin to depreciate day by day, and our heads are not working well. Especially the destruction of various narcotics such as pregnancy, childbirth, and illness, coupled with the trivial life of the elderly and children at home and abroad, memory will also decline. The degree to which you want to immerse yourself in words is becoming less and less, so everyone will feel that 50 articles are very difficult to memorize! Two days after the
link was sent, the department leader printed a paper version of 50 new violations for each of us. I read it in my hand. Some employees think it should be commonly used by electricians and mechanics, but we don't need it. Why should we memorize it? The leader said to us in a drizzle : "Don't we have a clause that says to protect others from harm? If we don't know more than professional skills, how can we protect others from harm? " A sentence convinced everyone and recited it carefully.
I think it is a little difficult to memorize it all at once. So, I made a plan, a total of 50, a day back ten, the amount is not too much, five days can be back. After five days, get up early every day to recite it silently, recall it before going to bed, and input it into the brain for long-term preservation. And we can recite according to the order of daily affairs. For example, every day when we go to work, we have to handle the work ticket before we have to overhaul, so the first one is about not handling the work ticket. When running a job ticket, we have to analyze risks and control measures, so Article 2 says that it is illegal to carry out unconventional operations without risk analysis and implementation of control measures. Then the ticket is to go to the relevant departments to do, the ticket person does not follow the prescribed procedures to review, issue, a mere formality is also illegal. After finishing the ticket, we should start the preparation work before the overhaul. We should talk about special operations. We should have the responsibility of the guardian and the guardian at the scene. The guardian will violate the rules and regulations. Before starting to work, multi-type and multi-level maintenance work shall be carried out at the same time, and personnel shall be set up to command and supervise on site. Next is the external maintenance, installation and transformation personnel, as well as the different problems in the maintenance, and finally the mental state of the staff. If we understand this logic, we will remember it better. (Luo Meiyan)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page